We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

June 26, 2006

APOTEX, INC. v. CEPHALON, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 7, 2017

    Apotex, Ranbaxy End Pay-For-Delay Suit Over Narcolepsy Med

    A Pennsylvania federal judge on Friday ended Canadian pharmaceutical company Apotex’s pay-for-delay suit accusing generic-drug maker Ranbaxy of violating antitrust laws by accepting a settlement with Cephalon that improperly delayed generic alternatives to the narcolepsy medication Provigil from entry into the market.

17 other articles on this case. View all »

Parties

To view the parties, register now.